Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin J. Glennie is active.

Publication


Featured researches published by Martin J. Glennie.


Journal of Biological Chemistry | 1998

Internalization of the lymphocytic surface protein CD22 is controlled by a novel membrane proximal cytoplasmic motif.

Claude H. T. Chan; Junsheng Wang; Ruth R. French; Martin J. Glennie

CD22 is a key receptor on B-lymphocytes that modulates signaling during antigenic stimulation. We have defined a novel cytoplasmic motif in human CD22 that controls its unusually rapid turnover at the plasma membrane. Chimeric and mutated CD22α cDNA vectors were constructed and stably transfected in CD22-negative Jurkat T-lymphocytic cells. Two assays were employed to measure CD22α internalization: first, cytoplasmic uptake of radioiodinated anti-CD22 monoclonal antibody; and second, lethal targeting of a toxin, saporin, into cells via CD22 using bispecific F(ab′)2([anti-CD22 × anti-saporin]) antibody. Results showed that CD22α lacking a cytoplasmic tail was not internalized and that replacement of the cytoplasmic tail of CD19 with that of CD22α resulted in a chimeric molecule that behaved like CD22α and internalized rapidly. Step-wise deletion of the cytoplasmic tail of CD22α located the internalization motif to a polar region of 11 residues (QRRWKRTQSQQ) proximal to the plasma membrane, a part of the molecule predicted to form a coil or turn structure. Interestingly, additional CD22 mutants showed that the two glutamine residues sandwiching the serine are critical to internalization but that the serine itself is not.


Archive | 2016

COMBINED USE OF FC GAMMA RIIB (CD32B)-SPECIFIC ANTIBODY AND CD20-SPECIFIC ANTIBODY

Mark S. Cragg; Martin J. Glennie; Ali Roghanian; Stephen A. Beers; Peter M. W. Johnson; Sean Lim; Bjoern Frendeus; Ingrid Teige


Archive | 2013

subsequent radioimmunotherapy lymphoma: the effect of prior rituximab dosing and tumor burden on Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell

Yong Du; Val Lewington; James Thom; Maureen A. Zivanovic; Peter W. M. Tim; M. Illidge; Mike Bayne; Nick Brown; Samantha Chilton; Mark S. Cragg; Martin J. Glennie


Archive | 2013

segregation into lipid 'rafts' Complement-mediated lysis by anti-CD20 mAb correlates with

Ruth R. French; Martin J. Glennie; Mark S. Cragg; Suzanne Marie Morgan; A. V. Filatov


Archive | 2013

activation I (rituximab-like) reagents in B-cell depletion regardless of complement Type II (tositumomab) anti-CD20 monoclonal antibody out performs type

Anupama Ahuja; Mark J Shlomchik; Mark S. Cragg; Martin J. Glennie; Stephen A. Beers; Claude H. T. Chan; Sonya James; Ruth R. French; Kathrine E. Attfield


Archive | 2013

antibody therapy is critically dependent on CD27 costimulation Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal

Alison L. Tutt; Aymen Al-Shamkhani; Martin J. Glennie; Ruth R. French; Vadim Y. Taraban; Graham R. Crowther; Tania F. Rowley; Juliet Gray


Archive | 2013

This information is current as Consumption and Receptor Internalization Limited by Monoclonal Antibody Receptor IIB (CD32b) in the Mouse Is γ Immunotherapy Targeting Inhibitory Fc

Mark S. Cragg; Martin J. Glennie; Christine A. Penfold; Cherié L. Butts; Peter Boross; Ruth R. French; Claude H. T. Chan; Kerry L. Cox; L. Williams; Alison L. Tutt; Stephen A. Beers


Archive | 2013

B-cell lymphoma RI/CD64-directed bispecific antibodies in γ Therapeutic efficacy of Fc

Martin J. Glennie; Jamie Honeychurch; Alison L. Tutt; Thomas Valerius; Ingmar A. F. M. Heijnen


Archive | 2013

radiation to eradicate lymphoma in radioimmunotherapy Antibody-induced intracellular signaling works in combination with

Timothy M. Illidge; Yong Du; Jamie Honeychurch; Mark S. Cragg; Mike Bayne; Martin J. Glennie; Peter M Johnson


Archive | 2011

not due to activation of complement depleting activity of type II anti-CD20 mAb is - Response: Superior B cell

Stephen A. Beers; Mark S. Cragg; Martin J. Glennie

Collaboration


Dive into the Martin J. Glennie's collaboration.

Top Co-Authors

Avatar

Mark S. Cragg

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Ruth R. French

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alison L. Tutt

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mike Bayne

University of Southampton

View shared research outputs
Top Co-Authors

Avatar

Sonya James

University of Southampton

View shared research outputs
Top Co-Authors

Avatar

Yong Du

University College Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge